Monitoring of anticoagulation in extracorporeal membrane oxygenation: is anti-Xa the new activated clotting time?

Pediatr Crit Care Med. 2015 Jan;16(1):87-9. doi: 10.1097/PCC.0000000000000298.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Extracorporeal Membrane Oxygenation / adverse effects*
  • Female
  • Hemorrhage / etiology*
  • Humans
  • Male

Substances

  • Anticoagulants